Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Spatial Vision
|
July 14, 2001
Reference frame for rapid visual processing of line orientation
L M Doherty, D H Foster
Spatial Vision
|
September 24, 1999
Limitations of rapid parallel processing in the detection of long and short oriented line targets
L M Doherty, D H Foster
Journal of Steroid Biochemistry
|
October 1, 1988
Quantitative determination of nuclear estrogen receptors by an enzyme immunoassay: applicability and caveats
L G Kral, L M Doherty, S C Brooks
Neurology
|
March 21, 2007
Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note
M G Chheda, J Drappatz, N J Greenberger, et al.
Journal of Neuro-Oncology
|
December 15, 2010
Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure
C Lu-Emerson, A D Norden, J Drappatz, et al.
Journal of Neuro-Oncology
|
October 11, 2011
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
J Drappatz, E Q Lee, S Hammond, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Spatial Vision
|
July 14, 2001
Reference frame for rapid visual processing of line orientation
L M Doherty, D H Foster
Spatial Vision
|
September 24, 1999
Limitations of rapid parallel processing in the detection of long and short oriented line targets
L M Doherty, D H Foster
Journal of Steroid Biochemistry
|
October 1, 1988
Quantitative determination of nuclear estrogen receptors by an enzyme immunoassay: applicability and caveats
L G Kral, L M Doherty, S C Brooks
Neurology
|
March 21, 2007
Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note
M G Chheda, J Drappatz, N J Greenberger, et al.
Journal of Neuro-Oncology
|
December 15, 2010
Retrospective study of dasatinib for recurrent glioblastoma after bevacizumab failure
C Lu-Emerson, A D Norden, J Drappatz, et al.
Journal of Neuro-Oncology
|
October 11, 2011
Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma
J Drappatz, E Q Lee, S Hammond, et al.
Page
of 1